ANXA6 and triple-negative breast carcinoma: Yet, AnxA6-dependent cooperativity of growth factors and lipoproteins may only occur in certain cells, as tyrosine kinase inhibitor treatment of triple-negative breast cancer cells caused AnxA6 upregulation and was associated with LE-Chol accumulation, possibly contributing to drug resistance46.